The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment

被引：4

作者：

Gaebel, Wolfgang ^{[1
,2
]}

Stricker, Johannes ^{[1
,2
]}

Hasan, Alkomiet ^{[3
]}

Falkai, Peter ^{[4
]}

McIntyre, John S. ^{[5
]}

Kerst, Ariane ^{[1
,2
]}

机构：

[1] Heinrich Heine Univ, LVR Klinikum Dusseldorf, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany

[2] WHO Collaborating Ctr Qual Assurance & Empowermen, Dusseldorf, Germany

[3] Univ Augsburg, Med Fac, Bezirkskrankenhaus Augsburg, Dept Psychiat Psychotherapy & Psychosomat, Augsburg, Germany

[4] Univ Hosp LMU Munich, Dept Psychiat & Psychotherapy, Munich, Germany

[5] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA

来源：

SCHIZOPHRENIA RESEARCH | 2021年 / 229卷

关键词：

Antipsychotic; Guideline; Long-term; Maintenance; Quality; Schizophrenia;

D O I：

10.1016/j.schres.2020.11.011

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

[No abstract available]

引用

页码：137 / 139

页数：3

共 50 条

[21] LONG-TERM TREATMENT OF MOOD DISORDERS IN SCHIZOPHRENIA [J].

AZORIN, JM .

ACTA PSYCHIATRICA SCANDINAVICA, 1995, 91 :20-23

[22] New antipsychotics in long-term treatment of schizophrenia [J].

Möller, HJ .

PSYCHOPHARMAKOTHERAPIE, 2004, 11 (01) :2-10

[23] The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents [J].

Spivak, B ;

Musin, E ;

Mester, R ;

Gonen, N ;

Talmon, Y ;

Guy, N ;

Roitman, S ;

Kupchik, M ;

Kotler, M ;

Weizman, A .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (04) :229-232

[24] Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies [J].

Murasaki, Mitsukuni ;

Inoue, Yoshifumi ;

Nakamura, Hiroshi ;

Kinoshita, Toshihiko .

ANNALS OF GENERAL PSYCHIATRY, 2021, 20 (01)

[25] Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies [J].

Mitsukuni Murasaki ;

Yoshifumi Inoue ;

Hiroshi Nakamura ;

Toshihiko Kinoshita .

Annals of General Psychiatry, 20

[26] Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966 [J].

Moilanen, J. M. ;

Haapea, M. ;

Jaaskelainen, E. ;

Veijola, J. M. ;

Isohanni, M. K. ;

Koponen, H. J. ;

Miettunen, J. .

EUROPEAN PSYCHIATRY, 2016, 36 :7-14

[27] Sustained drug delivery optimizes long-term treatment of patients with schizophrenia [J].

Chue, PS ;

D'Hoore, P ;

Ramstack, JM .

ACTA NEUROPSYCHIATRICA, 2004, 16 (06) :319-325

[28] Efficacy of aripiprazole (amdoal) in the long-term treatment of schizophrenia [J].

Tsukarzi, E. E. .

ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (03) :94-97

[29] RISK FACTORS FOR NONCOMPLIANCE WITH ANTIPSYCHOTIC MEDICATION IN LONG-TERM TREATED CHRONIC SCHIZOPHRENIA PATIENTS [J].

Krzystanek, Marek ;

Krysta, Krzysztof ;

Janas-Kozik, Malgorzata ;

Martyniak, Ewa ;

Rybakowski, Janusz .

PSYCHIATRIA DANUBINA, 2019, 31 :S543-S548

[30] A critical analysis of recent data on the long-term outcome of antipsychotic treatment [J].

Moncrieff, Joanna ;

Steingard, Sandra .

PSYCHOLOGICAL MEDICINE, 2019, 49 (05) :750-753

← 1 2 3 4 5 →